Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 3/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19212098 | 0.98 | — | — | |
| SCHEMBL9738090 | 0.89 | — | — | |
| SCHEMBL17488891 | 0.75 | MMP2 (0.37) | MMP2CA12CA1CA2CA9 | |
| SCHEMBL29467371 | 0.71 | FDPS (0.41) | MMP2CA12CA1CA2CA9 | |
| SCHEMBL29796765 | 0.71 | FDPS (0.41) | MMP2CA12CA1CA2CA9 | |
| SCHEMBL27792299 | 0.71 | MMP2 (0.37) | MMP2CA12CA1CA2CA9 | |
| SCHEMBL15792481 | 0.71 | MMP2 (0.35) | MMP2CA12CA1CA2CA9 | |
| Methane SCHEMBL11749189 | 0.70 | FDPS (0.39) | MMP2CA12CA1CA2CA9 | |
| SCHEMBL27936234 | 0.70 | MMP2 (0.33) | MMP2CA12CA1CA2CA9 | |
| SCHEMBL3827313 | 0.70 | ACHE (0.45) | MMP2CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109195641-B | Improved implant treatment with phosphonic acid compounds | 纳米桥接分子股份公司 | 2021-07-27 | — | — | CN | claimed |
| EP-3413934-A1 | IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS | Nano Bridging Molecules SA (CH) | 2018-12-19 | — | — | EP | disclosed |
| WO-2017137623-A1 | IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS | NANO BRIDGING MOLECULES SA (CH) | 2017-08-17 | — | — | WO | disclosed |